A nurse is caring for a client who has chemotherapy-induced peripheral neuropathy. The nurse should expect the client to report having experienced which of the following symptoms?

Rationale: A. Jerking movements of the extremities (myoclonus) are not typical of chemotherapy-induced peripheral neuropathy. These movements are usually associated with neurological disorders or medication side effects involving the central nervous system. B. Extremities that turn blue when exposed to cold describe Raynaud’s phenomenon, which is a circulatory issue, not a neuropathic complication. Chemotherapy-induced neuropathy primarily affects nerve function rather than blood flow. C. A tingling feeling in the extremities (paresthesia) is the hallmark symptom of chemotherapy-induced peripheral neuropathy (CIPN). Clients may also experience numbness, burning, or shooting pain in the hands and feet due to damage to sensory nerves caused by agents such as vincristine, cisplatin, or paclitaxel. This can interfere with balance, fine motor tasks, and mobility. D. Spasms of the extremities are more commonly associated with electrolyte imbalances or neuromuscular irritability, not peripheral neuropathy.